Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Effect of Vonoprazan Versus Dexlansoprazole in Treatment of Gastroesophageal Reflux Disease in Egyptian Patients: A Prospective Comparative Study

NCT06778395 is registered in ClinicalTrials.gov with Ayman Magd Eldin Mohammad Sadek as lead sponsor.

NCT NCT06778395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06778395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Effect of Vonoprazan Versus Dexlansoprazole in Treatment of Gastroesophageal Reflux Disease in Egyptian Patients: A Prospective Comparative Study
Lead sponsor
Ayman Magd Eldin Mohammad Sadek
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2024
Completion date
December 31, 2024
Enrollment
136 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease, proton pump inhibitor, vonoprazan